Amplitude Surgical S.A. (AMPLI.PA)
Amplitude Surgical S.A. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Valence, FR. The stock last traded at $6.25, up 0.00% on the session, giving a market capitalisation of $299.8M. Its beta of 0.12 implies it has historically moved less than the broad market.
Amplitude Surgical S.A. specializes in the design, development, and commercialization of surgical solutions for orthopedics. Its comprehensive portfolio addresses both primary and revision procedures, targeting a variety of conditions affecting the hip, knee, and lower limbs, with a particular focus on foot and ankle pathologies. This includes a wide array of knee and hip prostheses, as well as specialized implants for the foot and ankle. Beyond implants, Amplitude Surgical offers advanced technological platforms like AMPLIVISION, a computer-aided surgical system; i.M.A.G.E., a customized, single-use instrumentation solution; and E.T.O.I.L.E., an innovative platform facilitating less-invasive anterior surgical approaches. The company also supplies the necessary instrumentation for implant fitting. Operating globally, its products reach approximately 30 countries through an extensive network of distributors and agents, serving patients, surgeons, and healthcare institutions. Established in 1997, Amplitude Surgical S.A. maintains its headquarters in Valence, France.
Amplitude Surgical S.A. is most often compared with the following Healthcare names: